Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Leukemia

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Leukemia in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, B1
Hattori, N1
Liu, B1
Nakayama, Y1
Kitagawa, K1
Inagaki, C1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Leukemia

ArticleYear
Suppression of cell proliferation with induction of p21 by Cl(-) channel blockers in human leukemic cells.
    European journal of pharmacology, 2004, Mar-19, Volume: 488, Issue:1-3

    Topics: Blotting, Northern; Blotting, Western; Cell Cycle; Cell Division; Chloride Channels; CLC-2 Chloride

2004
chemdatabank.com